Larry Bressler

Head, Global Rare Disease Value (Marketing) and Market Access at Chiesi

Speaker

With over 20 years of pharmaceutical industry experience, Lawrence (Larry) Bressler has developed a reputation for being an effective leader, strategist, and planner. He has a broad range of proficiency across rare disease and primary care pharmaceutical/vaccine sales and marketing.

Prior to joining Chiesi GRD, Larry served as the VP, Global Launch Lead for Rhythm Pharmaceuticals, where he was responsible for leading the launch strategy and developing solutions for physicians, including the creation of a global genetic testing program.  Larry also held leadership roles at Shire, where he led the prelaunch global commercial planning in the disease areas of eosinophilic esophagitis and hereditary angioedema.

Prior to moving into rare diseases, Larry worked at GSK and Merck and held a series of roles of increasing responsibility.  In his last role at GSK, he was the Senior Director of the Pediatric Vaccine Commercial Strategy Team and was responsible for delivering gross annual revenue of greater than $1B.